- Home
- EXAI
EXAI
Exscientia Plc
as 07-26-2024 4:00pm EST
Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
| Founded: | 2012 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 726.7M | IPO Year: | 2021 |
| Target Price: | $8.67 | AVG Volume (30 days): | 478.5K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.86 - $9.12 | Next Earning Date: | 08-08-2024 |
| Revenue: | $25,138,462 | Revenue Growth: | -24.61% |
| Revenue Growth (this year): | 208.42% | Revenue Growth (next year): | -35.72% |
Latest Exscientia Plc News
EXAI Breaking Stock News: Dive into EXAI Ticker-Specific Updates for Smart Investing
Clinical Trials Arena
5 days ago
Big Pharma is forging an increased number of partnerships with artificial intelligence vendors for drug discovery services
Pharmaceutical Technology
7 days ago
Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial
MT Newswires
8 days ago
Exscientia to Acquire Full Control of Cancer Drug Program From GT Apeiron
Business Wire
9 days ago
Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout
Zacks
14 days ago
Amazon (AMZN) Expands AWS Clientele With Exscientia Deal
MT Newswires
17 days ago
Exscientia Expands Amazon Web Services Partnership to Support Drug Discovery Platform
Business Wire
17 days ago
Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
Simply Wall St.
22 days ago
Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Compare EXAI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EXAI Exscientia Plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.